Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

US Jury Finds CVS, Walmart, and Walgreens Contributed to the Opioid Epidemic in Two Ohio Counties

11/23/2021 | 01:47pm EST


ę MT Newswires 2021
All news about CVS HEALTH CORPORATION
01/18CVS HEALTH : How mobile health screenings increase access to care
PU
01/18CVS HEALTH : Breaking down health barriers by building affordable housing
PU
01/18CVS HEALTH : Bringing health home to seniors in Atlanta
PU
01/18CVS HEALTH : Alleviating food insecurity in Fresno, California
PU
01/18CVS HEALTH : Attacking food insecurity in Hartford, Connecticut
PU
01/14Walgreens, CVS shut some stores as Omicron variant complicates staffing issues
RE
01/14NORTH AMERICAN MORNING BRIEFING : Stock Futures Muted Ahead of Bank Earnings
DJ
01/12MARKETSCREENER’S WORLD PRESS REVIEW : January 12, 2022
01/11Walgreens, CVS cut paid sick leave for workers in line with CDC guidance
RE
01/11Health Care Up As Demand For Covid Products Seen Rising -- Health Care Roundup
DJ
More news
Analyst Recommendations on CVS HEALTH CORPORATION
More recommendations
Financials (USD)
Sales 2021 291 B - -
Net income 2021 8 224 M - -
Net Debt 2021 50 761 M - -
P/E ratio 2021 17,3x
Yield 2021 1,91%
Capitalization 138 B 138 B -
EV / Sales 2021 0,65x
EV / Sales 2022 0,59x
Nbr of Employees 256 500
Free-Float -
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 28
Last Close Price 104,51 $
Average target price 114,26 $
Spread / Average Target 9,33%
EPS Revisions
Managers and Directors
Karen S. Lynch President, Chief Executive Officer & Director
Shawn M. Guertin Chief Financial Officer & Executive Vice President
David Wyatt Dorman Chairman
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Jonathan C. Roberts Chief Operating Officer & Executive Vice President